APA (7th ed.) Citation

He, S., Niu, G., Shang, J., Deng, Y., Wan, Z., Zhang, C., . . . Shen, H. Retraction Note: The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway. BMC.

Chicago Style (17th ed.) Citation

He, Shanyang, Gang Niu, Jianhong Shang, Yalan Deng, Zhiyong Wan, Cai Zhang, Zeshan You, and Hongwei Shen. Retraction Note: The Oncogenic Golgi Phosphoprotein 3 like Overexpression Is Associated with Cisplatin Resistance in Ovarian Carcinoma and Activating the NF-κB Signaling Pathway. BMC.

MLA (9th ed.) Citation

He, Shanyang, et al. Retraction Note: The Oncogenic Golgi Phosphoprotein 3 like Overexpression Is Associated with Cisplatin Resistance in Ovarian Carcinoma and Activating the NF-κB Signaling Pathway. BMC.